Washington Capital Management Inc. continued to hold its position in shares of Steris Plc (NYSE:STE) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 8,000 shares of the medical equipment provider’s stock at the end of the second quarter. Steris Plc comprises approximately 0.7% of Washington Capital Management Inc.’s holdings, making the stock its 29th largest position. Washington Capital Management Inc.’s holdings in Steris Plc were worth $652,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Bragg Financial Advisors Inc purchased a new position in shares of Steris Plc during the first quarter worth about $1,159,000. Louisiana State Employees Retirement System increased its position in shares of Steris Plc by 1.4% in the first quarter. Louisiana State Employees Retirement System now owns 21,400 shares of the medical equipment provider’s stock worth $1,486,000 after buying an additional 300 shares in the last quarter. Legal & General Group Plc increased its position in shares of Steris Plc by 31.0% in the first quarter. Legal & General Group Plc now owns 56,190 shares of the medical equipment provider’s stock worth $3,902,000 after buying an additional 13,294 shares in the last quarter. Morgan Stanley increased its position in shares of Steris Plc by 28.3% in the first quarter. Morgan Stanley now owns 266,537 shares of the medical equipment provider’s stock worth $18,514,000 after buying an additional 58,776 shares in the last quarter. Finally, Russell Investments Group Ltd. increased its position in shares of Steris Plc by 57.5% in the first quarter. Russell Investments Group Ltd. now owns 132,035 shares of the medical equipment provider’s stock worth $9,171,000 after buying an additional 48,188 shares in the last quarter. Institutional investors own 92.40% of the company’s stock.
Steris Plc (NYSE STE) opened at 85.13 on Friday. The firm has a market capitalization of $7.26 billion, a PE ratio of 60.89 and a beta of 1.33. Steris Plc has a one year low of $63.80 and a one year high of $87.49. The stock has a 50 day moving average of $83.11 and a 200-day moving average of $75.64.
Steris Plc (NYSE:STE) last posted its quarterly earnings results on Tuesday, August 8th. The medical equipment provider reported $0.85 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.80 by $0.05. The business had revenue of $608 million for the quarter, compared to analyst estimates of $597.66 million. Steris Plc had a return on equity of 11.39% and a net margin of 4.63%. The business’s revenue was down 4.8% compared to the same quarter last year. During the same period in the prior year, the company posted $0.79 EPS. On average, equities analysts predict that Steris Plc will post $4.06 EPS for the current year.
The company also recently declared a quarterly dividend, which will be paid on Thursday, September 28th. Investors of record on Tuesday, August 29th will be given a dividend of $0.31 per share. This is a positive change from Steris Plc’s previous quarterly dividend of $0.28. This represents a $1.24 annualized dividend and a dividend yield of 1.46%. The ex-dividend date is Friday, August 25th. Steris Plc’s dividend payout ratio is currently 80.00%.
COPYRIGHT VIOLATION WARNING: “Steris Plc (NYSE:STE) Stake Held by Washington Capital Management Inc.” was originally reported by Community Financial News and is the sole property of of Community Financial News. If you are accessing this piece on another publication, it was copied illegally and republished in violation of U.S. & international trademark & copyright legislation. The original version of this piece can be read at https://www.com-unik.info/2017/08/19/steris-plc-nyseste-position-maintained-by-washington-capital-management-inc-updated-updated.html.
STE has been the topic of a number of research analyst reports. Zacks Investment Research raised shares of Steris Plc from a “sell” rating to a “hold” rating in a report on Friday, June 23rd. KeyCorp raised shares of Steris Plc from a “sector weight” rating to an “overweight” rating and set a $89.00 price objective on the stock in a report on Wednesday, May 3rd. BidaskClub cut shares of Steris Plc from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Raymond James Financial, Inc. raised their price objective on shares of Steris Plc from $90.00 to $95.00 and gave the stock an “outperform” rating in a report on Wednesday, August 9th. Finally, Wellington Shields cut shares of Steris Plc from a “gradually accumulate” rating to a “hold” rating in a report on Monday, June 5th. Two analysts have rated the stock with a hold rating and five have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $86.75.
In other Steris Plc news, insider Daniel A. Carestio sold 4,745 shares of the stock in a transaction on Tuesday, June 13th. The stock was sold at an average price of $80.08, for a total value of $379,979.60. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of the stock in a transaction on Friday, June 2nd. The stock was sold at an average price of $80.05, for a total value of $800,500.00. The disclosure for this sale can be found here. Over the last three months, insiders have sold 46,354 shares of company stock worth $3,805,772. Corporate insiders own 2.55% of the company’s stock.
Steris Plc Company Profile
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
What are top analysts saying about Steris Plc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Steris Plc and related companies.